All stock lists
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.80+0.10 (+2.70%)
Market cap
$2.03B
Health Score
Analyst consensus
Listed since
Apr 16, 2021
Website
Insider Score
––Not scored
RXRX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
RXRX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New RXRX patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RXRX from public contracts
Source: USAspending.gov
Recently reported changes in RXRX holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing RXRX, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for RXRX. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.